EDOC.L
Global X Telemedicine & Digital Health UCITS ETF
EDOC invests in companies positioned to benefit from further advances in the field of telemedicine and digital health. This includes companies involved in Telemedicine, Health Care Analytics, Connected Health Care Devices, and Administrative Digitization.
Global
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 4.9 M
ASSETS UNDER MGMT
68 bp
EXPENSES
Fund Basics
| Inception date | Dec 16, 2020 |
| Regulation | UCITS |
| ISIN | IE00BLR6QB00 |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| MASIMO CORPORATION | 6.1 % |
| ILLUMINA INC | 6.1 % |
| QUEST DIAGNOSTICS | 5.5 % |
| LABCORP HOLDINGS | 5.2 % |
| TWIST BIOSCIENCE CORP. | 4.7 % |
| DEXCOM INC | 4.5 % |
| RESMED INC | 4.3 % |
| VERACYTE INC | 4.2 % |
| ALIBABA HEALTH INFORMATION TECHNOLOGY LT | 3.9 % |
| QIAGEN NV | 3.9 % |
Constituent Breakdown
| Number of holdings | 40 |
| Herfindahl-Hirschman Index | 374 |
| Wgt avg mkt cap (mns) | $13,370 |
| Large cap (>$10bn) | 47.2% |
| Mid cap ($2-10bn) | 34.6% |
| Small cap (<$2bn) | 15.9% |
| Developed mkts. | 92.9% |
| Emerging mkts. | 7.1% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 80.0 % |
 |
CHINA | 6.4 % |
 |
HONG KONG | 3.9 % |
 |
NETHERLANDS | 3.9 % |
 |
AUSTRALIA | 2.2 % |
 |
JAPAN | 1.4 % |
Historical Performance
Standardized Performance (as of 02/28/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -4.1% | 0.2% | 4.2% | -4.0% | -12.3% | -- | -- | -11.0% |
| Dividend Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -- | -- | 0.0% |
| Total Returns | -4.1% | 0.2% | 4.2% | -4.0% | -12.3% | -- | -- | -11.0% | Ann. Volatility | 20.5% | 23.6% | 24.5% | 24.8% | 27.8% | -- | -- | 27.7% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.26 | 5% |
| MSCI EAFE | 0.31 | 5% |
| MSCI Emg Mkts | 0.36 | 7% |
Liquidity Measures
| Avg. volume (000) | 1 |
| ADV traded (mns) | $0 |
| Turnover | 0.2% |
| Avg. Bid/Ask (% of price) | 0.00% |
Technical Indicators
| 30d moving avg. (EMA) | $8.45 |
| Relative strength (RSI) | 43 |
| MACD/Signal | -0.15/-0.18 |
| Bollinger Bands (Upper/Lower) | $8.66/$7.90 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. EDOC.L |
Expenses vs. EDOC.L |
ALTAR Score™ vs. EDOC.L |
|---|---|---|---|---|
| GNOM.L | Global X Genomics & Biotechnology UCITs ETF | 14.8% | -18 bp | -4.0% |
| XGEN.DE | Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | 10.9% | -38 bp | -0.3% |
| HEAL.L | iShares Healthcare Innovation UCITS ETF | 10.1% | -28 bp | +1.9% |
Risk and Returns: EDOC.L vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/6/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
0.6%
ALTAR SCORE™
7th
PERCENTILE
AVOID
ETFRC RATING
There are 579 funds in the Global Equity category with an average
ALTAR Score™ of 4.6% and a standard deviation
of 2.7%. EDOC.L's ALTAR Score™ is approximately -1.5 standard
deviations above the category average. This places EDOC.L in the 7th percentile
among funds in the category.
Sell-Side Consensus
$10.58
PRICE TARGET
+40.2%
UPSIDE